1. Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma. (17th December 2018) Authors: Rule, Simon; Cook, Gordon; Russell, Nigel H.; Hunter, Ann; Robinson, Stephen; Morley, Nick; Sureda, Anna; Patrick, Pip; Clifton‐Hadley, Laura; Adedayo, Toyin; Kirkwood, Amy; Peggs, Karl S. Journal: British journal of haematology Issue: Volume 184:Number 6(2019) Page Start: 999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive, phase 2, proof-of-concept trial. Issue 3 (March 2022) Authors: Fisher, Benjamin A; Veenith, Tonny; Slade, Daniel; Gaskell, Charlotte; Rowland, Matthew; Whitehouse, Tony; Scriven, James; Parekh, Dhruv; Balasubramaniam, Madhu S; Cooke, Graham; Morley, Nick; Gabriel, Zoe; Wise, Matthew P; Porter, Joanna; McShane, Helen; Ho, Ling-Pei; Newsome, Philip N; Rowe, An... Journal: Lancet Issue: Volume 10:Issue 3(2022) Page Start: 255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rituximab in the treatment of non-Hodgkin's lymphoma – a critical evaluation of randomized controlled trials. (August 2013) Authors: Griffin, Morag Meriel; Morley, Nick Journal: Expert opinion on biological therapy Issue: Volume 13:Number 5(2013:May) Page Start: 803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial. Issue 2 (February 2022) Authors: Toback, Seth; Galiza, Eva; Cosgrove, Catherine; Galloway, James; Goodman, Anna L; Swift, Pauline A; Rajaram, Sankarasubramanian; Graves-Jones, Alison; Edelman, Jonathan; Burns, Fiona; Minassian, Angela M; Cho, Iksung; Kumar, Lakshmi; Plested, Joyce S; Rivers, E Joy; Robertson, Andreana; Dubovsky,... Journal: Lancet Issue: Volume 10:Issue 2(2022) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The 5‐year follow‐up of a real‐world observational study of patients in the United Kingdom and Ireland receiving ibrutinib for relapsed/refractory mantle cell lymphoma. (23rd May 2020) Authors: Tucker, David; Morley, Nick; MacLean, Peter; Vandenberghe, Elisabeth; Booth, Stephen; Parisi, Lori; Rule, Simon Journal: British journal of haematology Issue: Volume 192:Number 6(2021) Page Start: 1035 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗